Advertisement
Original communication| Volume 105, ISSUE 1, P72-78, January 1989

Self-rated psychiatric symptoms in patients operated on because of primary hyperparathyroidism and in patients with long-standing mild hypercalcemia

  • Charlotte Joborn
    Affiliations
    From the Departments of Internal Medicine, Psychiatry, and Surgery, University Hospital, Uppsala, Sweden

    From the Department of Internal Medicine, County Hospital, Gävle, Sweden
    Search for articles by this author
  • Jerker Hetta
    Affiliations
    From the Departments of Internal Medicine, Psychiatry, and Surgery, University Hospital, Uppsala, Sweden

    From the Department of Internal Medicine, County Hospital, Gävle, Sweden
    Search for articles by this author
  • Lars Lind
    Affiliations
    From the Departments of Internal Medicine, Psychiatry, and Surgery, University Hospital, Uppsala, Sweden

    From the Department of Internal Medicine, County Hospital, Gävle, Sweden
    Search for articles by this author
  • Jonas Rastad
    Affiliations
    From the Departments of Internal Medicine, Psychiatry, and Surgery, University Hospital, Uppsala, Sweden

    From the Department of Internal Medicine, County Hospital, Gävle, Sweden
    Search for articles by this author
  • Göran Ȧkerström
    Affiliations
    From the Departments of Internal Medicine, Psychiatry, and Surgery, University Hospital, Uppsala, Sweden

    From the Department of Internal Medicine, County Hospital, Gävle, Sweden
    Search for articles by this author
  • Sverker Ljunghall
    Correspondence
    Reprint requests: Sverker Ljunghall, MD, Department of Internal Medicine, University Hospital, S-751 85 Uppsala, Sweden.
    Affiliations
    From the Departments of Internal Medicine, Psychiatry, and Surgery, University Hospital, Uppsala, Sweden

    From the Department of Internal Medicine, County Hospital, Gävle, Sweden
    Search for articles by this author
      This paper is only available as a PDF. To read, Please Download here.

      Abstract

      Self-rated psychiatric symptoms were investigated in 30 patients referred for surgery because of primary hyperparathyroidism (HPT) (serum calcium, 2.87 ± 0.21 mmol/L) in 38 subjects detected in a health screening, with 15 years of mild hypercalcemia and probable HPT (serum calcium, 2.66 ± 0.09 mmol/L), and in38 normocalcemic control subjects. The psychiatric symptomatology was evaluated by use of the Hopkins Symptom Checklist (HSCL-56), a self-rating symptom scale. The patients with verified HPT had the highest mean HSCL score, 89.1 ± 20.1 before surgery, compared with 76.6 ± 17.0 (p < 0.01) in the health survey hypercalcemic patients and 73.8 ± 16.0 (p < 0.001) in the controls. The factors for anxiety, depression, and cognitive symptoms were the most pronounced in the HPT patients and were also increased among the mildly hypercalcemic persons of the health survey, compared with the controls. Somatic symptoms such as headache, back pain, chest pain, and weakness were equally common in HPT and in the controls, and measurements of isometric muscle strength of knee extension did not demonstrate reduction of muscle strength in the health survey hypercalcemic patients. Follow-up of the HPT patients 1year after parathyroid surgery revealed a marked improvement in mental health (HSCL score 73.2 ± 13.7, p < 0.001). In the health survey hypercalcemic patients, neither the psychiatric symptomatology nor the muscle strength were influenced by 6 months of oral vitamin D therapy (alphacalcidol). The results demonstrate that psychiatric symptoms are experienced frequently by patients with HPT and minimum to moderate increases in the serum calcium level and that these disturbances are reversed by parathyroid surgery.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Surgery
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Christensson T
        • Hellström K
        • Wengle B
        • Alveryd A
        • Wikland B
        Prevalence of hypercalcemia in a health screening in Stockholm.
        Acta Med Scand. 1976; 200: 131-137
        • Palmér M
        • Adami HO
        • Bergström R
        • Jakobsson S
        • Ȧkerström G
        • Ljunghall S
        Patients with primary hyperparathyroidism operated on over a 24-year period: temporal trends of clinical and laboratory findings.
        J Chronic Dis. 1987; 4: 121-130
        • Ȧkerström G
        • Rudberg C
        • Grimelius L
        • Bergström R
        • Johansson H
        • Ljunghall S
        • Rastad J
        Histologic parathyroid abnormalities in an autopsy series.
        Hum Pathol. 1986; 17: 520-527
        • Coe F
        • Favus M
        Does mild, asymptomatic hyperparathyroidism require surgery?.
        N Engl J Med. 1980; 302: 224-225
        • Posen S
        • Clifton-Bligh P
        • Reeve TS
        • Wagstaffe C
        • Wilkinson M
        Is parathyroidectomy of benefit in primary hyperparathyroidism?.
        Q J Med. 1985; 215: 241-251
        • Health H
        • Hodgson III, SF
        • Kennedy MA
        Primary hyperparathyroidism—incidence, morbidity and potential economic impact in a community.
        N Engl J Med. 1980; 302: 189-193
        • Joborn C
        • Hetta J
        • Palmér M
        • Ȧkerström G
        • Ljunghall S
        Psychiatric symptomatology in patients with primary hyperparathyroidism.
        Ups J Med Sci. 1986; 91: 77-87
        • Joborn C
        • Hetta J
        • Rastad J
        • Ȧkerström G
        • Ägren H
        • Ljunghall S
        Psychiatric symptoms and cerebrospinal fluid monoamine metabolites in primary hyperparathyroidism.
        Biol Psychiatry. 1988; 23: 149-158
        • Malette LE
        • Bilezikian JP
        • Health DA
        • Aurbach GD
        Primary hyperparathyroidism: clinical and biochemical features.
        Medicine. 1974; 53: 127-146
        • Petersen P
        Psychiatric disorders inprimary hyperparathyroidism.
        J Clin Endocrinol Metab. 1968; 28: 1491-1495
        • Slatopolsky E
        • Weerts C
        • Thielan J
        • Horst R
        • Harter H
        • Martin KJ
        Marked suppression of secondary hyperparathyroidism by intravenous administration of 1,25-dihydroxsycholecalciferol in uremic patients.
        J Clin Invest. 1984; 74: 2136-2142
        • Kleeman CR
        • Norris K
        • Coburn JW
        Is the clinical expression of primary hyperparathyroidism a function of the long-term vitamin D status of the patient?.
        Mineral Electrolyte Metab. 1987; 13: 305-310
        • Palmér MO
        • Jakobsson S
        • Ȧkerström G
        • Ljunghall S
        Prevalence of hypercalcemia in a health survey: a 14-year follow-up study of serum calcium values.
        Eur J Clin Invest. 1988; 18: 39-46
        • Derogatis LR
        • Lipman RS
        • Rickels K
        • Uhlenhuth EH
        • Covi L
        The Hopkins Symptom Checklist (HSCL): a self-report symptom inventory.
        Behav Sci. 1974; 19: 1-15
        • Goldberg HL
        • Finnerty R
        Comparison of buspirone in two separate studies.
        J Clin Psychiatry. 1982; 43: 87-91
        • Benson L
        • Rastad J
        • Wide L
        • Ȧkerström G
        • Ljunghall S
        Stimulation of parathyroid hormone secretion by EDTA-infusion—a test for the differential diagnosis of hypercalcaemia.
        Acta Endocrinol. 1986; 111: 498-506
        • Numann PJ
        • Torppa AJ
        • Blumetti AE
        Neuropsychologic deficits associated with primary hyperparathyroidism.
        Surgery. 1984; 96: 1119-1123
        • Feighner JP
        • Merideth CH
        • Claghorn JL
        Multicenter placebo-controlled evaluation of nomifensine treatment in depressed outpatients.
        J Clin Psychiatry. 1984; 45: 47-51
        • Rickels K
        • Wiseman K
        • Norstad N
        • Singer M
        Buspirone and diazepam in anxiety: a controlled study.
        J Clin Psychiatry. 1982; 43: 81-86
      1. Joborn C, Rastad J, Stȧlberg E, Ȧkerström G, Ljunghall S. Muscle function in patients with pr Muscle Nerve (in press).

        • Hedman I
        • Grimby G
        • Tisell LE
        Improvement of muscle strength after treatment for hyperparathyroidism.
        Acta Chir Scand. 1984; 150: 521-524
        • Joborn C
        • Joborn H
        • Rastad J
        • Ȧkerström G
        • Ljunghall S
        Maximal isometric muscle strength in patients with primary hyperparathyroidism before and after parathyroid surgery.
        Br J Surg. 1988; 75: 77-80
        • Wersäll-Robertsson E
        • Hamberger B
        • Ehrén H
        • Eriksson E
        • Granberg PO
        Increase in muscular strength following surgery for primary hyperparathyroidism.
        Acta Med Scand. 1986; 220: 233-235
        • Patten BM
        • Bilezikian JP
        • Malette LE
        • Prince A
        • Engel WK
        • Aurbach GP
        Neuromuscular disease in primary hyperparathyroidism.
        Ann Intern Med. 1974; 80: 182-193
        • van Praag HM
        Neutrotransmitters and CNS disease: depression.
        Lancet. 1982; ii: 1259-1264
        • Ȧsberg M
        • Bertilsson L
        • Mȧrtensson B
        • Scalia-Tomba G-P
        • Thorén P
        • Träskman-Bendz L
        CSF monoamine metabolites in melancholia.
        Acta Psychiatr Scand. 1984; 69: 201-219
        • Dubovsky SL
        • Franks RD
        Intracellular calcium ions in affective disorders: a review and a hypothesis.
        Biol Psychiatry. 1983; 18: 781-797
        • Jimerson DC
        • Wood JH
        • Post RM
        Cerebrospinal fluid calcium: clinical correlates in psychiatric and seizure disorders.
        in: Wood JH Neurobiology of CSF. Plenum Press, New York1980: 743-749
        • Strumpf WE
        • Sar M
        • Clark SA
        • DeLuca HF
        Brain target sites for 1,25-dihydroxyvitamin D3.
        Science. 1982; 215: 1403-1405
        • Sonnenberg J
        • Luine VN
        • Krey LG
        • Christakos S
        1,25-dihydroxy-vitamin D3 treatment results in increased choline acetyltransferase activity in specific brain nuclei.
        Endocrinology. 1986; 118: 1433-1439